Roche and Spark Therapeutics, Inc. announce extension of tender offer

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) ("Spark") announced that Roche has extended the offering period of its previously announced tender offer to purchase all of the outstanding shares of common stock (the "Shares") of Spark for USD 114.50 per Share, net to the seller thereof in cash, without

Source: World Pharma News - December 9, 2019 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news